4/A//SEC Filing
Deignan Charles A. 4/A
Accession 0001209191-22-005437
CIK 0001539029other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:51 PM ET
Size
8.1 KB
Accession
0001209191-22-005437
Insider Transaction Report
Form 4/AAmended
Deignan Charles A.
Chief Financial Officer
Transactions
- Award
Common Stock
2022-01-18+46,250→ 362,699 total - Award
Stock Option (Right to Buy)
2022-01-18+138,750→ 138,750 totalExercise: $2.19Exp: 2032-01-18→ Common Stock (138,750 underlying)
Footnotes (2)
- [F1]These shares are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of the Issuer. The shares underlying the RSU vest in 4 equal annual installments on each of January 18, 2023, January 18, 2024, January 18, 2025 and January 18, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
- [F2]One-fourth of the shares underlying this option vest on January 18, 2023 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001664690
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:51 PM ET
- Size
- 8.1 KB